id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_eb3v35mzffhfldcyuvzyhi467q	Changjiao Yan	Relationship between BRAFV600E and clinical features in papillary thyroid carcinoma	2019	9	.pdf	application/pdf	6220	706	58	epidemiological risk factors and clinical outcomes among patients with papillary thyroid Results: The BRAF V600E mutation was present in 83.7% of patients (1715 of 2048). BRAF V600E mutation and extrathyroidal invasion, distant metastatic and disease mutation observed in PTC, BRAF V600E has received outcomes in patients with PTC, such as large tumor size, Table 1 Association of BRAF V600E with epidemiologic features of all PTC. In patients without BRAF V600E mutations, Table 3 Multivariate logistic regression analysis of BRAF V600E mutation of all PTC. In patients with BRAF V600E mutations, the disease BRAF mutation in papillary thyroid cancer and its value in meaning of BRAF V600E mutation in papillary thyroid carcinoma. value of BRAF mutation in thyroid cancer. 26 Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, Viola D, BRAF V600E mutation and recurrence of papillary thyroid cancer. BRAF V600E mutation and mortality in patients with papillary 	./cache/work_eb3v35mzffhfldcyuvzyhi467q.pdf	./txt/work_eb3v35mzffhfldcyuvzyhi467q.txt